Cargando…

Campylobacter insulaenigrae bacteremia with meningitis: a case report

BACKGROUND: The bacterium Campylobacter insulaenigrae was first isolated from marine mammals of Scotland in 2004. Only one case of C. insulaenigrae infection in humans has been previously reported. CASE PRESENTATION: An 89-year-old Japanese man without dementia was admitted to our hospital, because...

Descripción completa

Detalles Bibliográficos
Autores principales: Kyotani, Moe, Kenzaka, Tsuneaki, Akita, Hozuka, Arakawa, Soichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252270/
https://www.ncbi.nlm.nih.gov/pubmed/34210285
http://dx.doi.org/10.1186/s12879-021-06353-8
_version_ 1783717263813115904
author Kyotani, Moe
Kenzaka, Tsuneaki
Akita, Hozuka
Arakawa, Soichi
author_facet Kyotani, Moe
Kenzaka, Tsuneaki
Akita, Hozuka
Arakawa, Soichi
author_sort Kyotani, Moe
collection PubMed
description BACKGROUND: The bacterium Campylobacter insulaenigrae was first isolated from marine mammals of Scotland in 2004. Only one case of C. insulaenigrae infection in humans has been previously reported. CASE PRESENTATION: An 89-year-old Japanese man without dementia was admitted to our hospital, because he presented with a fever of 38 °C and weakness in right leg since 5 days. He had organized chronic subdural hematoma (CSH), and no history of pre-infection. At the time of admission, he had paralysis of the extraocular muscle, ataxia, and low manual muscle test score of the right side. He was suspected to have Miller Fisher syndrome; however, these symptoms improved without any treatment. On day 22 in the hospital, the patient presented a fever of 38.8 °C, left cranial nerve disorder, and hemiplegia. On day 25, the patient presented with signs of meningeal irritation; cerebrospinal fluid examination indicated an increase in the number of apocytes and a low glucose level. A contrast magnetic resonance imaging (MRI) scan of the patient’s head indicated a contrast enhancement effect in his right meninges. The blood culture showed presence of spirillums; 16S rRNA gene sequencing confirmed that the spirillums in the blood culture were Campylobacter insulaenigrae (C. insulaenigrae). We started treatment with meropenem for bacteremia and meningitis. When the symptoms improved, meropenem was replaced with ampicillin, based on the result of the drug sensitivity test. The treatment continued for 4 weeks. CONCLUSIONS: We report the first case of meningitis caused by C. insulaenigrae bacteremia in humans, and the second clinical report of C. insulaenigrae infection in humans. The bacterial strains isolated from humans and marine mammals had different genotypes. This suggests that different genotypes could be responsible for differences in the hosts. Further case studies are needed to establish the reasons behind the difference in the manifestations of C. insulaenigrae infections reported so far.
format Online
Article
Text
id pubmed-8252270
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-82522702021-07-06 Campylobacter insulaenigrae bacteremia with meningitis: a case report Kyotani, Moe Kenzaka, Tsuneaki Akita, Hozuka Arakawa, Soichi BMC Infect Dis Case Report BACKGROUND: The bacterium Campylobacter insulaenigrae was first isolated from marine mammals of Scotland in 2004. Only one case of C. insulaenigrae infection in humans has been previously reported. CASE PRESENTATION: An 89-year-old Japanese man without dementia was admitted to our hospital, because he presented with a fever of 38 °C and weakness in right leg since 5 days. He had organized chronic subdural hematoma (CSH), and no history of pre-infection. At the time of admission, he had paralysis of the extraocular muscle, ataxia, and low manual muscle test score of the right side. He was suspected to have Miller Fisher syndrome; however, these symptoms improved without any treatment. On day 22 in the hospital, the patient presented a fever of 38.8 °C, left cranial nerve disorder, and hemiplegia. On day 25, the patient presented with signs of meningeal irritation; cerebrospinal fluid examination indicated an increase in the number of apocytes and a low glucose level. A contrast magnetic resonance imaging (MRI) scan of the patient’s head indicated a contrast enhancement effect in his right meninges. The blood culture showed presence of spirillums; 16S rRNA gene sequencing confirmed that the spirillums in the blood culture were Campylobacter insulaenigrae (C. insulaenigrae). We started treatment with meropenem for bacteremia and meningitis. When the symptoms improved, meropenem was replaced with ampicillin, based on the result of the drug sensitivity test. The treatment continued for 4 weeks. CONCLUSIONS: We report the first case of meningitis caused by C. insulaenigrae bacteremia in humans, and the second clinical report of C. insulaenigrae infection in humans. The bacterial strains isolated from humans and marine mammals had different genotypes. This suggests that different genotypes could be responsible for differences in the hosts. Further case studies are needed to establish the reasons behind the difference in the manifestations of C. insulaenigrae infections reported so far. BioMed Central 2021-07-01 /pmc/articles/PMC8252270/ /pubmed/34210285 http://dx.doi.org/10.1186/s12879-021-06353-8 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Case Report
Kyotani, Moe
Kenzaka, Tsuneaki
Akita, Hozuka
Arakawa, Soichi
Campylobacter insulaenigrae bacteremia with meningitis: a case report
title Campylobacter insulaenigrae bacteremia with meningitis: a case report
title_full Campylobacter insulaenigrae bacteremia with meningitis: a case report
title_fullStr Campylobacter insulaenigrae bacteremia with meningitis: a case report
title_full_unstemmed Campylobacter insulaenigrae bacteremia with meningitis: a case report
title_short Campylobacter insulaenigrae bacteremia with meningitis: a case report
title_sort campylobacter insulaenigrae bacteremia with meningitis: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8252270/
https://www.ncbi.nlm.nih.gov/pubmed/34210285
http://dx.doi.org/10.1186/s12879-021-06353-8
work_keys_str_mv AT kyotanimoe campylobacterinsulaenigraebacteremiawithmeningitisacasereport
AT kenzakatsuneaki campylobacterinsulaenigraebacteremiawithmeningitisacasereport
AT akitahozuka campylobacterinsulaenigraebacteremiawithmeningitisacasereport
AT arakawasoichi campylobacterinsulaenigraebacteremiawithmeningitisacasereport